Skip to main content

Table 2 Mouse models for studying roles of TGF-β signaling in obesity-related diseases

From: Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation

Gene

Mouse Model

Model Design

Diet

Model Phenotype

Ref.

TGF-β1

TGF-β1−/−

(C57BL/6)

Disruption of TGF-β1 Exon 3 with a neomycin cassette

High-fat diet

Resistant to adipose tissue hypertrophy, liver steatosis, and insulin resistance (20 wks)

(Lee et al. 2023)

TGF-β3

TGF-β1Lβ3/Lβ3

Ligating PCR products of TGF-β1 LAP with sequence for the mature HA-tagged ligands of murine TGF-β3, murine TGF-β2, and porcine TGF-β1

High-fat diet

Weight loss and improved glucose tolerance

(8 wks)

(Hall et al. 2013)

TGF-βRI

TGF-βRIAdKO (C57BL/6)

TβRI floxed mice intercrossed with aP2-Cre mice

High-fat diet

Weight loss and glucose intolerance (24 wks)

(Wankhade et al. 2018)

TGF-βRII

TGF-βRIIΔHEP

(C57BL/6)

Albumin-Cre recombinase transgenic mice intercrossed with Tgfbr2flox/flox mice

High-fat diet

Lower MASLD scores and reduce liver weight (16 wks)

(Zhao et al. 2022)

SMAD2

β-cell-specific SMAD2−/− (C57BL/6J)

Ins1cre mice intercrossed with SMAD2fx/fx

High-fat diet

Improved glucose tolerance, insulin secretion, and insulin sensitivity (12 wks)

(Saleh et al. 2021)

SMAD3

SMAD3−/−

(C57BL/6J and Lep ob/ob mice)

Disruption of SMAD3 exon 8 with neomycin cassette

High-fat diet

Weight loss and insulin resistance (10 wks)

(Yadav et al. 2011)

SMAD3

SMAD3−/−

(C57BL/6J)

SMAD3 heterozygous mice intercrossed

High-fat diet

Weight loss and insulin resistance (18 wks)

(Tan et al. 2011)

SPTBN1

SPTBN1LSKO

(C57BL/6J)

Disruption of exons 24 to 26 of Sptbn1, with neomycin cassette. Neo cassettes removed by intercrossing with Flp mice. Sptbn1-Flox mice intercrossed with Albumin-Cre.

High-fat diet and Western diet

Resistant to obesity, MASLD, and MASH

(Rao et al. 2021)

SPTBN1

Aldh2−/−SPTBN1+/−

(C57BL/6Jx129SvEv)

Aldh2−/− mice intercrossed with Sptbn1+/− mice

Western diet

Metabolic syndrome, Obesity, MASH

(Yang et al. 2024)